Algert Global LLC Amphastar Pharmaceuticals, Inc. Transaction History
Algert Global LLC
- $4.77 Billion
- Q2 2025
A detailed history of Algert Global LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Algert Global LLC holds 124,290 shares of AMPH stock, worth $2.95 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
124,290
Previous 17,300
618.44%
Holding current value
$2.95 Million
Previous $502,000
468.53%
% of portfolio
0.06%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
262Shares Held
32.9MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...